IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — HSCSW

Balance Sheet

(in millions USD)
MetricQ3 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023
Cash & Equivalents3.402.601.952.797.080.100.581.933.084.27
Accounts Receivable0.00----0.000.010.00------0.00
Inventory0.660.650.660.650.670.670.680.680.680.68
Total Current Assets5.103.633.794.428.691.812.032.874.135.44
Property, Plant & Equipment0.050.070.050.060.060.050.060.060.060.07
Intangible Assets1.661.611.631.621.57----------
Total Non-current Assets*2.462.072.202.022.110.560.570.610.640.13
Total Assets7.555.706.006.4410.802.372.603.484.775.57
Accounts Payable0.410.410.320.280.421.090.451.040.800.46
Total Current Liabilities4.273.571.573.011.713.531.901.993.141.54
Total Non-current Liabilities0.630.350.250.280.460.491.221.750.551.14
Total Liabilities4.903.921.813.302.174.023.123.743.692.68
Retained Earnings(82.52)(74.03)(80.53)(78.18)(65.52)(63.87)(62.12)(59.12)(57.78)(55.98)
Total Stockholder Equity2.651.794.183.148.63(1.65)(0.52)(0.26)1.082.89

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Total Revenue0.000.000.000.000.000.000.000.010.00--0.000.000.000.00
Cost of Revenue0.000.00----0.000.000.000.000.00--0.000.000.000.00
Gross Profit0.000.00----0.000.000.000.010.00--0.000.000.000.00
Research & Development0.480.640.931.030.731.001.050.510.760.570.530.640.850.43
Selling, General & Admin2.061.290.991.341.350.880.831.030.820.771.060.670.931.00
Total Operating Expenses2.541.931.922.372.071.881.881.541.571.331.601.311.771.43
Operating Income(2.54)(1.93)(1.92)(2.37)(2.07)(1.87)(1.88)(1.53)(1.57)(1.33)(1.60)(1.31)(1.77)(1.43)
Interest Expense------------0.020.120.180.040.030.030.030.14
Net Income(2.75)(1.99)(2.09)(2.54)(2.35)(2.05)(1.85)(1.64)(1.75)(1.37)(1.63)(1.34)(1.81)(1.57)
Basic EPS--(0.63)(1.86)(2.57)(0.85)(1.58)(18.68)(0.03)(0.16)(0.13)(0.14)(0.16)(0.22)(0.28)
Diluted EPS----(1.86)(2.57)(0.85)(1.58)(18.68)(0.03)(0.16)(0.13)(0.14)(0.16)(0.22)(0.28)

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Operating Cash Flow(1.68)(5.75)(1.59)(5.82)(2.33)(1.95)(1.54)(2.14)(0.99)(1.40)(1.86)(0.97)(0.77)(1.81)
Capital Expenditures0.000.000.000.000.01--0.050.010.000.000.010.000.000.01
Free Cash Flow*(1.68)(5.75)(1.59)(5.83)(2.35)--(1.59)(2.15)(0.99)(1.41)(1.87)(0.97)(0.77)(1.82)
Investing Cash Flow0.00(0.04)(0.01)(0.02)(0.02)-0.00(0.11)(0.01)-0.00-0.00(0.01)-0.000.00(0.01)
Financing Cash Flow(0.06)8.090.102.631.513.650.389.130.510.321.603.80(0.12)5.17

* Derived from reported values

Dividends Per Share

(USD)
MetricQ3 2026
Dividends Per Share0.00